IL22 and neoplasm: NCR+ subset promote TLS formation and immune recruitment (12, 178–181)NCR- ILC3s produce IL-22 and IL-17, promote tumor growth and inflammation. ILC3-ILCreg conversion contributes to immune evasion (83, 108, 178, 182–187)